Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barohn

Showing results (311-320 of 345) with videos related to

Pageof 35
Sort By:
Muscle & Nerve|November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosisSalman Bhai, Todd Levine, Dan Moore, et al.
Neurology|January 24, 2016
Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohortJennifer Murphy, Pam Factor-Litvak, Raymond Goetz, et al.
Science Translational Medicine|March 25, 2016
Targeting protein homeostasis in sporadic inclusion body myositisMhoriam Ahmed, Pedro M Machado, Adrian Miller, et al.
Annals of Neurology|March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophyKathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
Neurology|June 17, 2016
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravisMamatha Pasnoor, Jianghua He, Laura Herbelin, et al.
The Lancet. Neurology|September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trialPedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Annals of Neurology|September 11, 2009
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase IIIPetra Kaufmann, John L P Thompson, Gilberto Levy, et al.
Muscle & Nerve|December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravisKatherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALSPaul H Gordon, Ying-Kuen Cheung, Bruce Levin, et al.
Pageof 35

Showing results (311-320 of 345) with videos related to

Sort By:
Pageof 35
Muscle & Nerve|November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosisSalman Bhai, Todd Levine, Dan Moore, et al.
Neurology|January 24, 2016
Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohortJennifer Murphy, Pam Factor-Litvak, Raymond Goetz, et al.
Science Translational Medicine|March 25, 2016
Targeting protein homeostasis in sporadic inclusion body myositisMhoriam Ahmed, Pedro M Machado, Adrian Miller, et al.
Annals of Neurology|March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophyKathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
Neurology|June 17, 2016
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravisMamatha Pasnoor, Jianghua He, Laura Herbelin, et al.
The Lancet. Neurology|September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trialPedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Annals of Neurology|September 11, 2009
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase IIIPetra Kaufmann, John L P Thompson, Gilberto Levy, et al.
Muscle & Nerve|December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravisKatherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALSPaul H Gordon, Ying-Kuen Cheung, Bruce Levin, et al.
Pageof 35